Market Research Logo

Biotechnology in Germany

Biotechnology in Germany

Summary

Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Germany biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

  • The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
  • The German biotechnology industry had total revenues of $9.5bn in 2017, representing a compound annual growth rate (CAGR) of 6.8% between 2013 and 2017.
  • The medical/healthcare segment was the industry's most lucrative in 2017, with total revenues of $4.7bn, equivalent to 49.7% of the industry's overall value.
  • Germany’s biotechnology industry is driven by its aging population, which is raising demand for medical drugs.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Germany
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Germany
  • Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Germany biotechnology market with five year forecasts
Reasons to buy
  • What was the size of the Germany biotechnology market by value in 2017?
  • What will be the size of the Germany biotechnology market in 2022?
  • What factors are affecting the strength of competition in the Germany biotechnology market?
  • How has the market performed over the last five years?
  • What are the main segments that make up Germany's biotechnology market?


Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Boehringer Ingelheim GmbH
Merck & Co., Inc.
MorphoSys AG
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: Germany biotechnology industry value: $ billion, 2013-17
Table 2: Germany biotechnology industry category segmentation: $ billion, 2017
Table 3: Germany biotechnology industry geography segmentation: $ billion, 2017
Table 4: Germany biotechnology industry value forecast: $ billion, 2017-22
Table 5: Boehringer Ingelheim GmbH: key facts
Table 6: Boehringer Ingelheim GmbH: key financials ($)
Table 7: Boehringer Ingelheim GmbH: key financials (€)
Table 8: Boehringer Ingelheim GmbH: key financial ratios
Table 9: Merck & Co., Inc.: key facts
Table 10: Merck & Co., Inc.: key financials ($)
Table 11: Merck & Co., Inc.: key financial ratios
Table 12: MorphoSys AG: key facts
Table 13: MorphoSys AG: key financials ($)
Table 14: MorphoSys AG: key financials (€)
Table 15: MorphoSys AG: key financial ratios
Table 16: Germany size of population (million), 2013-17
Table 17: Germany gdp (constant 2005 prices, $ billion), 2013-17
Table 18: Germany gdp (current prices, $ billion), 2013-17
Table 19: Germany inflation, 2013-17
Table 20: Germany consumer price index (absolute), 2013-17
Table 21: Germany exchange rate, 2013-17
List of Figures
Figure 1: Germany biotechnology industry value: $ billion, 2013-17
Figure 2: Germany biotechnology industry category segmentation: % share, by value, 2017
Figure 3: Germany biotechnology industry geography segmentation: % share, by value, 2017
Figure 4: Germany biotechnology industry value forecast: $ billion, 2017-22
Figure 5: Forces driving competition in the biotechnology industry in Germany, 2017
Figure 6: Drivers of buyer power in the biotechnology industry in Germany, 2017
Figure 7: Drivers of supplier power in the biotechnology industry in Germany, 2017
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Germany, 2017
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Germany, 2017
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Germany, 2017
Figure 11: Boehringer Ingelheim GmbH: revenues & profitability
Figure 12: Boehringer Ingelheim GmbH: assets & liabilities
Figure 13: Merck & Co., Inc.: revenues & profitability
Figure 14: Merck & Co., Inc.: assets & liabilities
Figure 15: MorphoSys AG: revenues & profitability
Figure 16: MorphoSys AG: assets & liabilities

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report